ABSTRACT: The clinical significance of asymptomatic bronchial hyperrespon siveness (BHR) is not well-known. The aim of this study was to explore, in a crosssectional analysis, the characteristics of adolescent subjects with asymptomatic BHR, as compared to nonhyperresponsive subjects and those with symptomatic BHR. The subjects were selected by date of birth from the register of general prac titioners. The hypothesis that both asymptomatic and symptomatic BHR are rela ted to early childhood lower respiratory tract infections was also tested, in a historical cohort analysis.
Bronchial hyperresponsiveness (BHR) is characteris tic* though not specific, for asthma; it is also present in chronic airflow limitation, rhinitis and after upper or lower respiratory tract infections (LRTI) [1, 2] . In popu lation studies, up to 58% of hyperresponsive subjects did not report respiratory symptoms [3] [4] [5] . The clinical significance of asymptomatic BHR is, therefore, still unclear. Spontaneous remissions have been reported in children [6, 7] but poor perception of dyspnoea has also been suggested as an explanation [8] , Other studies have demonstrated that asymptomatic BHR precedes the development of asthma [9, 10] suggesting that it is a risk factor for development of asthma at a later stage. If this is true, it might be expected that, with respect to asthma characteristics, subjects with asymptomatic BHR would be comparable to those with symptomatic BHR (asthma), and would differ from subjects without BHR.
Z h o n g et al. [10] demonstrated an increased tenden cy to develop asthma in asymptomatic hyperresponsive adolescents with a history of acute respiratory illness in early childhood. This would support a theoretical model, which implies that LRTI in early childhood are a risk factor for the development of asthma [11, 12] . Acquired changes in the bronchial (sub)mucosa could manifest themselves as BHR, which may initially persist without symptoms, but may become symptomatic in later life, possibly because of environmental factors. If BHR is the essential link in the evolution from LRTI in early childhood to asthma, then this BHR should be related to the incidence of LRTI in early childhood, both for symptomatic and for asymptomatic BHR.
The aim of this study was to answer the following questions:
1. What is the prevalence of BHR, both asymptomatic and symptomatic forms, in a sample of subjects select ed from registers of general practitioners on the criter ion of age 10-23 yrs (hereafter, referred to as adolescents and young adults)? 2. Are both forms of BHR in adolescence and young adulthood related to LRTI in early childhood? 3. Do subjects with asymptomatic and those with symptomatic BHR have similar personal characteristics and clinical characteristics related to asthma?
Methods and materials
A cohort of children from general practice records was followed from birth to the age of 10-23 yrs, Morbid ity data was prospectively recorded from birth onwards. The respiratory status at the age of 10-23 yrs was stud ied by use of a questionnaire, spirometry and a hista mine challenge test.
Study population
The 581 participating subjects (40% of the original birth cohort) were recruited from the registers of the prac tice population of the Continuous Morbidity Registra tion (CMR), Department of General Practice, University of Nijmegen, The Netherlands. Subjects were recruited from these records, only on the basis of their date of birth. Under the structure of the Dutch health care sys tem, professional medical care can only be obtained through primary care. Listing with a general practitioner is compulsory under every insurance scheme, and each general practice has a fixed, identifiable and unselec ted list of patients [13, 14] .
The registration started in 1967, and the study was confined to all subjects born before 1979, to guarantee a follow-up of 10 yrs from birth. Of the 1,441 children born during that period, 492 had left the area at the time of the study, and 23 had died of a non-respiratory cause. The remaining 926 subjects were invited to take part in the study ( fig. 1) . A written and oral explanation was given to the subjects, and to their parents if they were aged <16 yrs. They were asked to complete a respira tory questionnaire and to undergo spirometry and a his tamine challenge test. Of this group, 581 subjects (63%) participated in this study. The data of 30 subjects were excluded from analyses and are referred to as nonperformers: three subjects were not able to perform repro ducible forced expiratory manoeuvres, seven could not finish the challenge test due to cough, although forced expiratory volume in one second (FEVi) was not sig nificantly decreased; and 20 subjects did not complete the questionnaire satisfactorily. None of the subjects had an initial FEVi <50% of predicted, or <1 L, so that all 551 participants underwent the histamine challenge test.
The CMR (the characteristics have been described elsewhere) [12, 15] provided the following informa tion: 1) the early childhood respiratory morbidity during the first 5 yrs of life, and the recent respiratory mor bidity during the 5 yrs preceding the start of this study; 2) data on age, sex and socioeconomic status; and 3) a family history (parents or siblings) of asthma. Data of chronic respiratory symptoms, smoking behaviour, airways obstruction, BHR and allergy were collected in the winter of [1989] [1990] .
The questionnaire was based on the standardized questionnaire on four respiratory symptoms (children's version) of the British Medical Research Council (BMRC) and the American Thoracic Society (ATS) [16] . Its re producibility had been found to be satisfactory [17] . All subjects completed the questionnaire by themselves.
The four questions on "chronic respiratory symptoms" are listed in table 1. A question on smoking habits was added by us. A subject was considered "symptomatic" in the case of an affirmative answer to at least one of the four questions on chronic symptoms.
Spirometry was carried out with a portable flowvolume meter (Microspiro HI-298, Chest Corp., Tokyo, Japan) [18] . Each subject had to perform three satisfac tory forced vital capacity (FVC) manoeuvres (values within 10% of each other). Data were taken from the high est sum of FVC and the FEV l . Subjects who had a FE V 1 <(FEVl pred -2 s d ) [19, 20] were considered to have airways obstruction. The provocative concentration of histamine causing a 20% decrease in FEVi (PC20) was assessed by means of the concise version of the European Respiratory Soc iety standardized tidal breathing procedure [20] . The combination of nebulizer and flow meter was calibra ted by a weighing method, to give an output of 0.13 mL-mhr1. The tests were taken by field workers trained and supervised by the university lung function labora tory. International recommendations were followed ex actly: the starting concentration was adapted according the FEVi, the FEVi/inspiratory vital capacity (VC) ratio, and the use of inhaled medication. Following a 2 min inhalation of saline, histamine concentrations of 0.03-16 mg^mL' 1 were inhaled. At 30 and 90 s after each inhalation, the forced expiratory manoeuvres were per formed to measure the response. The lowest FEVi value from an adequate maximum expiratory flow-volume (MEFV) curve was used for further evaluation. If the change in FEVi was less than 5%, the next dose was omitted. A 5 min interval was taken between the start of inhaling two successive doses. Bronchodilators and antihistamines, when used, were withheld at least 8 and 48 h, respectively, before the test. When a subject re ported a respiratory tract infection with fever in the last 6 weeks, the test was postponed until at least 6 weeks after the end of the infection. Results were expressed as the PC20 histamine. Subjects with a PC20 <8.0 mg-mL*1 were considered to have BHR [20] .
Allergic response to inhalant allergens was assessed by the Phadiatop-test (Kabi Pharmacia Diagnostics AB, Uppsala, Sweden) [21] . The test was considered posi tive when the ratio (subject's serum/reference serum) was higher than 1.
Analysis
An analysis was performed to assess whether the par ticipants in this study formed a representative sample of the original birth cohorts. For that purpose, they were compared with those of the original birth cohorts who did not belong to the study group. The comparison was made for sociodemographic features and for respira tory morbidity recorded in the first 5 yrs of life. The children who had left the practices before the age of 5 yrs (from whom not all the necessary data were avail able) were, therefore, ignored in this respect.
The study group was also compared with those who were invited for the study (n=926) but refused to par ticipate ("nonrespondents", n=375) regarding the respi ratory morbidity during the 5 yrs preceding the study, to assess the representativeness of the study group.
BHR was subdivided into symptomatic and asymp tomatic BHR, according to the reporting of chronic res piratory symptoms. Respiratory illness episodes in early childhood were separately related to BHR, both symp tomatic and asymptomatic. They were handled as dichotomous variables in a historical cohort analysis. For each relationship the relative risk (RR) and its 95% con fidence intervals (95% CIs) were assessed. The asymp tomatic hyperresponsive subjects and the symptomatic hyperresponders were compared with the nonhyperresponsive group and with each other, with respect to the following personal and clinical characteristics connec ted to asthma: sociodemographic features; recent respi ratory morbidity; family history (parents or siblings) of asthma; smoking habits (ever or never); allergy to inha lant allergens; and airways obstruction. All of the char acteristics were handled as dichotomous variables in a cross-sectional analysis. For each comparison the odds ratio (OR) and its 95% CIs were assessed.
A multiple logistic regression analysis was carried out, to ensure that each factor which was found to be re lated to BHR remained independently related to it after controlling for the other factors (excluding recent res piratory illnesses).
The analyses were repeated using more restrictive cri teria for BHR [22] , namely BHR in case of PC20 <4.0 and in case of <2.0 mg-mL-1, since the choice of the cut-off point is arbitrary [23, 24] . The value PC20 is reported to be dependent upon baseline airway patency [25] . In order to assess to what extent this was the case in the population of the present study, a Spearman's rank correlation coefficient was calculated between baseline FEVi %pred and log (PC20 +1) for those who achie ved a 20% fall in FEVi during bronchial challenge.
A Chi-squared test was used to determine the signif icance of the associations and the differences. All analy ses were performed using the Statistical Analysis System (SAS) package (SAS Institute Inc., Cary, NC, USA). A p-value of <0.05 was considered significant.
The study was approved by the Ethics Committee of the Faculty of Medical Sciences of the University of Nijmegen.
Results
The study group included significantly fewer male sub jects and fewer subjects of the highest social class and presented more episodes of respiratory morbidity in early childhood, compared to those of the original birth cohort not participating in the study (table 2).
In the study group, more subjects had episodes of acute bronchitis and hay fever in the 5 years preceding the study, as compared to nonrespondents (table 3) .
The distribution of PC20 values in the study group is shown in figure 2 . BHR could be demonstrated in 232 subjects (42% of the study group). One or more chro nic respiratory symptoms were present in 143 subjects (26%). Of those with BHR, 70% did not report any chronic respiratory symptom ( fig. 1) . Table 4 shows the relationship between respiratory illnesses in the first 5 yrs of life and BHR when aged 10-23 yrs. Only acute bronchitis in early childhood was related to BHR in adolescence and young adulthood (RR=1.3; p=0.02). However, this association was only present for those with symptomatic BHR.
The results of the comparisons between subject groups with asymptomatic BHR, symptomatic BHR, and non-BHR, with respect to a family history of asthma, smok ing habits, presence of allergy, of airways obstruction and of recent respiratory illnesses are shown in table 5. The comparison between subjects with asymptomatic BHR and non-BHR did not show significant differ ences.
In the symptomatic BHR group, more subjects had an allergy, airways obstruction or recent respiratory morbidity (namely, asthma, acute bronchitis and hay -Frequency histogram of the values of PC20 histamine found in the study group. PC20 was measured using the shortened version of the tidal breathing method, according to the European Respiratory Society (ERS) standardized lung function testing, Forty two percent of this population has a PC20 <8 mg*mL-1. PC20: provocative con centration of histamine producing a 20% decrease in forced expira tory volume in one second.
at least one episode.
fever), than in the nonhyperresponsive group and in the asymptomatic hyperresponsive group. No differences were found for sex, age, social class, family history of asthma and smoking behaviour between symptomatic BHR, asymptomatic BHR and non-BHR. Multiple logi stic regression analysis showed that acute bronchitis in early childhood, allergy and airways obstruction were independently related to BHR. When PC20 values of 4.0 and 2,0 mg-mL-1 histamine were chosen as cut-off points for BHR, the overall preva lence of BHR was 24 and 14%, respectively; with 60 and 53%, respectively, being asymptomatic (14 and 7%, respectively of the whole population). These more restric tive criteria did not essentially change the correlation between BHR and early childhood morbidity, nor bet ween BHR and the other factors examined; furthermore, the differences between asymptomatic and symptomatic BHR with respect to the associations with these factors remained the same.
For those who achieved a 20% fall in F E V l during bronchial challenge (PC20 <16 mg-mL1 histamine; n=369, 67% of the study group) no correlation was found between baseline FEVl % pred and log (PC20 +1) (Spearman's rank correlation coefficient = 0.04).
Discussion
The prevalence of BHR, defined by a PC20 <8 mg-mL'1, in this sample of adolescents and young adults was 42%, of which 70% were asymptomatic. This study indicat ed a relationship between BHR in adolescence and young adulthood and LRTI in early childhood for sub jects with symptomatic BHR, but not for those with asymptomatic BHR. No differences were found with respect to personal and clinical characteristics related to asthma between asymptomatic subjects with BHR and those without BHR. However, symptomatic BHR dif fered strongly from asymptomatic BHR in this regard. Relative risk (RR) and 95% confidence interval (95% Cl) for all subjects with bronchial hyperresponsiveness (BHR), defined a PC20 <8.0 mg-mL-1, for those with symptomatic BHR and for those with asymptomatic BHR, compared with nonhyperrespon sive subjects. in case of an affirmative answer to at least one of the questions on chronic respiratory symptoms; *: those wh< presented at least one episode, unless otherwise indicated, PC20: provocative concentration of histamine causing a 20% decreas in forced expiratory volume in one second. *: p<0.05; **: pcO.Ol. BHR was defined as a PC20 <8 mg-mLA *: missing 59 subjects. Odds Ratio (OR) and 95% confidence interval (95% Cl) foi all subjects (n=551) with asymptomatic BHR, compared with nonhyperresponsive subjects, and for those with symptomatic BHF compared with nonhyperresponsive subjects and with asymptomatic hyperresponders, respectively. #: in case of an affirmative answer to at least one of the questions on chronic respiratory symptoms; +: numbers and percentages refer to the whole popula tion (n=551); at least one episode;$: none of those with asymptomatic BHR presented laryngitis in 1985-1989. PC20: provoca tive concentration of histamine causing a 20% decrease in forced expiratory volume in one second. *: p<0.05; **: p<0 .01; *** pcO.OOl.
These findings are not consistent with the hypothesis that asymptomatic BHR constitutes a link between early childhood LRTI and asthma in later life. The present survey produced a high rate of BHR, higher than found in several other studies but not un common in comparable populations. BHR prevalence in random population studies ranges 4-64% [3-5, 23, 26] . These studies differ in the following factors: the prevalence of asthma and other atopic diseases; the age of the groups; the method used to measure bronchial responsiveness; and the threshold value for hyperre sponsiveness. In the present group of subjects, select ed from the records of general practices only on the basis of date of birth, the prevalence of asthma and hay fever, diagnosed during the 5 yrs preceding this study, was 4% and 11%, respectively. However, underdiag nosis in general practice has also been reported in many studies and has been shown in this study group [21] , The incidence of BHR in the present study lies be tween that found by C o ck cro ft et a l [23] (64% of a group of 300 students aged 2 0 -2 9 yrs, with a PC20 <8.0 mg-mL"1), and Backer et al. [28] (16% of 527 subjects aged 7-16 yrs, with a PC20 <8.0 mg-mL-1)* T rigg et a l [29] studied 366 subjects, recruited from four general practices in the UK, and performed standardized methacholine challenges. In the UK, persons are included in the registers of general practitioners on the same basis as in the Netherlands. They found a prevalence of BHR (defined by PC20 methacholine <2 mg-mL'1) of 23%. However, if they had applied the criterion of PC20 <8 mg-mL"1 to their data, they would have found a preva lence of 38% in a population recruited in a way compa rable to ours. T rigg et al. [29] also quoted an Australian study reporting a 35% prevalence of BHR in a popula tion of college students. Absence of symptoms has been found by others in a substantial proportion of hyperresponsive children (41%; 7% of the total population) [5] , and adults (59%; 14% of the total population) [4] . Consequently, we consider that the prevalence of BHR of 42% in our study group is high, but not unprece dented.
The questionnaire may have been biased in its Dutch translation towards the "Dutch hypothesis", by focus ing not only on asthma but also on COPD, especially with the questions on persistent chronic cough. This may have caused underreporting of asthma symptoms. However, chronic cough can be the sole clinical mani festation of asthma, and COPD is rare in the age cate gory of our study group.
The sample of the present study was selected by date of birth only from registers of general practitioners. The subjects were adolescents and young adults, who vol unteered to take part in the screening. Self-selection may have been a factor of influence, with "healthier" subjects less likely to participate. The comparison be tween our study group and the original birth cohorts did not reveal important differences. Therefore, it is unlike ly that selection bias was an important cause of the high prevalence of BHR found in this study. It was proba bly not the result of recent respiratory infections either, since in that case the histamine challenge test was post poned for 6 weeks. Most tests were performed in Dec ember and January, thus avoiding the influence of the grass pollen season.
A standardized method for testing BHR was used [20] , and the recommendations issued for its use were fol lowed exactly. Nebulizers and spirometers were cali brated regularly. Data from inadequately performed forced expiratory manoeuvres were excluded from the analy sis. The field testing was performed by trained personnel, supervised by the university lung function laboratory. As a consequence, we consider it unlikely that the high prevalence of BHR is due to poor methodology.
Early childhood LRTI and subsequent symptomatic or asymptomatic BHR
Acute bronchitis in early childhood was related to BHR at 10-23 yrs of age, a finding consistent with other stud ies relating early childhood respiratory illness and sub sequent BHR [30, 31] . It still has to be established whether this relationship results from early childhood LRTI, predisposing children to later BHR by triggering causal mechanisms, or whether the childhood LRTI are an early expression of BHR. It should be realized that, in this study, the classification "acute bronchitis" includes bronchiolitis, which is related to subsequent pulmonary function abnormalities and asthma [32] . However, this cannot be explored in the present study, due to lack of specific information. "Acute bronchitis" may be liable to misclassification: asthma-like symptoms, registered as acute bronchitis, could have been a first manifesta tion of asthma.
BHR should not be regarded as a specific entity in itself. It can merely result from airway narrowing. In the present study, no correlation was found between PC20 and baseline FEVl, which is in accordance with T wentyman et al. [33] , In our view, submucosal chan ges are more important determinants for BHR, as re flected in the hypothesis raised at the start of this study. However, our study did not support this hypothesis, as did a recent study in adolescents [10] . The latter study used a more restrictive definition of BHR, but applica tion of more restrictive definitions of BHR in our ana lysis, with lower histamine thresholds, did not change the results.
Characteristics of symptomatic and asymptomatic BHR
In the present study group, the considerable differ ences between asymptomatic and symptomatic BHR, and the similarities of the characteristics of asymptomatic BHR and non-BHR subjects, suggest that asymptomatic BHR is an entity, completely independent of asthma. Therefore, this does not support the hypothesis that asymp tomatic BHR precedes the development of asthma [9, 10] .
The present analysis does not allow firm conclusions regarding asymptomatic BHR as a risk factor for future asthma. To that end, further longitudinal studies are need ed, with a close follow-up of asymptomatic BHR.
It has been suggested that hyperresponsive subjects may be asymptomatic because of poor recognition of symptoms [8] . However, in the present study, sympto matic and asymptomatic hyperresponsive subjects also differed in a number of characteristics that are tiistinct from symptom perception. Therefore, perception does not seem to be a determining factor in explaining the difference between the two forms of BHR.
BHR in this and other surveys was assessed at one moment in time. The reproducibility of the histamine challenge test is good [20] , but bronchial responsive ness can vary considerably with time due to external factors [6, 34] , In general, the group with asymptomatic BHR had lower levels of BHR than the group with symptomatic BHR, and this mild BHR may disappear [6] . However, this does not seem an important factor, as the application of more restrictive definitions of BHR did not essentially change the results.
In summary, this study does not support the hypo thesis that asymptomatic bronchial hyperresponsive ness constitutes a link between early childhood lower respiratory illnesses and asthma in later life, nor for asymptomatic bronchial hyperresponsiveness to be a risk for subsequent asthma.
